All News

GRAFTYS Announces the Extension of its CE Mark for Its Calcium Phosphate Cements to Now Include GRAFTYS® HBS and GRAFTYS® Quickset for the Indication of Subchondral Bone Marrow Lesions around the Knee Joint (BML)

GRAFTYS SA, a company focused on development and commercialization of orthopedic biomaterials, is pleased to announce that it has obtained authorization from its notified body, NSAI (National Standards Authority of Ireland) for European commercialization for two of its cements (GRAFTYS®

One Symptom in New Medical Codes: Doctor Anxiety

By Robert Pear TERRE HAUTE, Ind. — The nation’s health care providers are under orders to start using a new system of medical codes to describe illnesses and injuries in more detail than ever before. The codes will cover common

10 Dallas ASCs to know

By Carrie Pallardy With a population of 6.9 million, Dallas is the third-largest city in Texas. It is home to a number of research and healthcare centers, such as Baylor University Medical Center, Medical City Dallas Hospital and the UT

MEDICREA: Results for the 1st Half of 2015

LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA group (Alternext Paris:FR0004178572 – ALMED,PEA-PME eligible), which specializes in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, announces its results for its 1st half to June 30th, 2015

In a First for the Orthopedic Industry, Bone Solutions of Dallas (BSI) Has Received Formal Patent Approval for Its Groundbreaking Magnesium Based Resorbable Bio-Material

Dallas, TX, September 10, 2015 –(PR.com)– Bone Solutions has most recently focused on launching its currently approved FDA extremity/trauma based applications by years end. Bone Solutions is also exploring dental and maxillofacial/cranial applications for this OsteoCrete™ based technology. The Company

nstitute of Applied Neurosciences licenses spine surgery implant exclusively to Amendia: 5 things to know

By Megan Wood The Institute for Applied Neurosciences, a nonprofit within the Medical University of South Carolina in Charleston, licensed a minimally invasive spine surgery implant to Amendia, a spine surgery medical device provider in Marietta, Ga. H…

Fragility fractures: Taking control of management, follow-up and assessment

The National Osteoporosis Foundation estimates 54 million Americans have low bone density or osteoporosis, with 50% of women and 25% of men older than 50 years expected to have an osteoporosis-related fragility fracture. “There are between 1.5 million and 2

Ex-Medtronic strategy veep Oesterle joins VC shop New Enterprise Associates | Personnel Moves

By Fink Densford Venture capital firm New Enterprise Associates said today it picked up ex-Medtronic (NYSE:MDT) executive veep Dr. Stephen Oesterle as a venture partner for the firm. Prior to being an executive veep for the medical giant, Oesterle served as

Q2 financials: 150 things to know about NuVasive, Stryker, J&J Orthopedics & more

By Anuja Vaidya Here are 150 insights and notes on the second quarter financial reports of some of the most prominent orthopedic and spine device companies. Medtronic (First quarter of 2015) 1. Medtronic reported $7.2 billion worldwide revenue for the

Radiolucent Pedicle Screw System Revolutionizes Care for Cancer Patients

ALTSTAETTEN, Switzerland, September 8, 2015 /PRNewswire/ — icotec AG, an innovative technology company focused on creating and manufacturing new products from Carbon/PEEK composites, revolutionizes spinal care for cancer patients.   “For the first time, radiotherapists, spinal surgeons and patients have a revolutionary treatment

© 2025 MedDeviceJobs.com | Powered by Careerleaf
v.4.6.7-9-gdb70438